Medicine, ageing and human longevity

EMBO Reports

Volumn 6, Issue SUPPL. 1, 2005, Pages

  McConnel, Charles ^a   Turner, Leigh ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; COLLAGEN; DERMATOLOGICAL AGENT; FINASTERIDE; MINOXIDIL; SILDENAFIL; TADALAFIL; VARDENAFIL;

AGED; AGING; ALOPECIA; ARTICLE; BIOETHICS; BIOTECHNOLOGY; CELL REGENERATION; DIET SUPPLEMENTATION; DNA MODIFICATION; DRUG COST; ERECTILE DYSFUNCTION; GENE THERAPY; GENE TRANSFER; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; LIFE EXPECTANCY; LIFESPAN; LIFESTYLE; LONGEVITY; LOTION; MORBIDITY; MORTALITY; NANOTECHNOLOGY; ONLINE SYSTEM; PENSION; PRIORITY JOURNAL; PUBLIC HEALTH; REGENERATIVE MEDICINE; REJUVENATION; RESOURCE ALLOCATION; RETIREMENT; RISK REDUCTION; ROBOTICS; SENESCENCE; SKIN DEFECT; SOCIAL ENVIRONMENT; SOCIAL JUSTICE; SOCIAL SUPPORT; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; WRINKLE; DEATH AND EUTHANASIA; DRUG EFFECT; ECONOMICS; ETHICS; HEALTH CARE AND PUBLIC HEALTH; HEALTH CARE DELIVERY; HEALTH ECONOMICS; MEDICAL ETHICS; MEDICINE; PHYSIOLOGY;

DEATH AND EUTHANASIA; HEALTH CARE AND PUBLIC HEALTH;

AGING; BIOTECHNOLOGY; DELIVERY OF HEALTH CARE; ECONOMICS, MEDICAL; ETHICS, MEDICAL; HUMANS; LONGEVITY; MEDICINE;

EID: 24744431687     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400431     Document Type: Article

References (33)

1. Bosworth BP, Keys B (2004) Increased life expectancy: A global perspective. In Aaron HJ, Schwartz WB (eds) Coping with Methuselah: The Impact of Molecular Biology on Medicine and Society pp247-283. Washington, DC, USA: Brookings Institution Press
2. Callahan D (2000) Death and the research imperative. N Engl J Med 342: 654-656
3. Carnes BA, Olshansky SJ, Grahn D (2003) Biological evidence for limits to the duration of life. Biogerontology 4: 31-45
4. Cowell A (2004) Demographic time bomb threatens pensions in Europe. The New York Times, Nov 26, pA3
5. Cutler DM, McClellan M (2001) Is technological change in medicine worth it? Health Aff (Millwood) 20: 11-29
6. Danzon P, Towse A (2000) The genomic revolution: Is the real risk under-investment rather than bankrupt health care systems? J Health Serv Res Policy 5: 253-255
7. de Grey AD, Ames BN, Andersen JK, Bartke A, Campisi J, Heward CB, McCarter RJ, Stock G (2002a) Time to talk SENS: Critiquing the immutability of human aging. Ann NY Acad Sci 959: 452-462
8. de Grey AD, Baynes JW, Berd D, Heward CB, Pawelec G, Stock G (2002b) Is human aging still mysterious enough to be left only to scientists? Bioessays 24: 667-676
9. Duenwald M (2004) New creams smooth wrinkles, but they're not Botox. The New York Times, Jun 22, pF5
10. Ehrlich I, Chuma H (1990) A model of the demand for longevity and the value of life extension. J Polit Econ 98: 761-782
11. Ehrlich I, Yin Y (2004) Explaining Diversities in Age-Specific Life Expectancies and Values of Life Saving: A Numerical Analysis. NBER Working Paper No. W10759. Cambridge, MA, USA: National Bureau of Economic Research
12. Freitas RA (2002) Death is an Outrage. www.rfreitas.com/Nano/ DeathIsAnOutrage.htm
13. Fukuyama F (2002) Our Posthuman Future: Consequences of the Biotechnology Revolution. New York, NY, USA: Farrar, Straus & Giroux
14. Garber AM, Goldman DP (2004)The changing face of health care. In Aaron HJ, Schwartz WB (eds) Coping with Methuselah: The Impact of Molecular Biology on Medicine and Society pp 105-123. Washington, DC, USA: Brookings Institution Press
15. Glannon W (2002) Identity, prudential concern, and extended lives. Bioethics 16: 266-283
16. Gorman J (2003) High-tech daydreamers investing in immortality. The New York Times, Nov 1, pB7
17. Grossman M (1972) The Demand for Health: A Theoretical and Empirical Investigation. Cambridge, MA, USA: National Bureau of Economic Research
18. Hall SS (2003) Merchants of Immortality: Chasing the Dream of Human Life Extension. Boston, MA, USA: Houghton Mifflin Co
19. Heard A (1997) They want to live. The New York Times Magazine, Sep 28, pp84-89
20. Horiuchi S (2000) Greater lifetime expectations. Nature 405: 744-745
21. Juengst ET, Binstock RH, Mehlman MJ, Post SG (2003) Antiaging research and the need for public dialogue. Science 299: 1323
22. Kass LR (2001) L'Chaim and its limits: Why not immortality? First Things 113: 17-24
23. Lichtenberg FR (2003) The Impact Of New Drug Launches On Longevity: Evidence From Longitudinal, Disease-Level Data From 52 Countries, 1982-2001. NBER Working Paper No. 9754. Cambridge, MA, USA: National Bureau of Economic Research
24. Lucke JC, Hall W (2005) Who wants to live forever? EMBO Rep 6: 98-102
25. Murphy K, Topel R (2003) Diminishing returns? The costs and benefits of improving health. Perspect Biol Med 46: S108-S128
26. Olshansky SJ, Carnes BA, Désesquelles A (2001) Prospects for human longevity. Science 291: 1491-1492
27. Pearce T (2005) Sticking it to Botox. The Globe and Mail, Jan 29, ppL1-L2
28. Rhoads C (2003) In deep crisis, Germany starts to revamp vast welfare state. The Wall Street Journal, Jul 10, pA1
29. Tuljapurkar S, Li N, Boe C (2000) A universal pattern of mortality decline in the G7 countries. Nature 405: 789-792
30. Vaupel JW et al (1998) Biodemographic trajectories of longevity. Science 280: 855-860
31. Whitney CR (1996) Rising health costs threaten generous benefits in Europe. The New York Times, Aug 6, pA1
32. Wilmoth JR (1998) The future of human longevity: A demographer's perspective. Science 280: 395-397
33. Wilmoth JR, Deegan LJ, Lundström H, Horiuchi S (2000) Increase of maximum life-span in Sweden, 1861-1999. Science 289: 2366-2368